1-6 of 6
Xiaoping Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen–Induced Lung Cancer and Determines the Efficacy of Immunotherapy

Chia-Hsin Liu, Zhong Chen, Kong Chen, Fu-Tien Liao, Chia-En Chung, Xiaoping Liu, Yu-Chun Lin, Phouthone Keohavong, George D. Leikauf, Yuanpu Peter Di
Journal: Cancer Research
Cancer Res (2021) 81 (1): 144–157.
https://doi.org/10.1158/0008-5472.CAN-20-1994
Published: 04 January 2021
View article titled, Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen–Induced Lung Cancer and Determines the Efficacy of Immunotherapy
Open the PDF for Lipopolysaccharide-Mediated Chronic Inflammation Promotes Tobacco Carcinogen–Induced Lung Cancer and Determines the Efficacy of Immunotherapy in another window
Includes: Supplementary data
Journal Articles

Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma

De-Chen Lin, Anand Mayakonda, Huy Q. Dinh, Pinbo Huang, Lehang Lin, Xiaoping Liu, Ling-wen Ding, Jie Wang, Benjamin P. Berman, Er-Wei Song, Dong Yin, H. Phillip Koeffler
Journal: Cancer Research
Series: Author Choice
Cancer Res (2017) 77 (9): 2255–2265.
https://doi.org/10.1158/0008-5472.CAN-16-2822
Published: 30 April 2017
View article titled, Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma
Open the PDF for Genomic and Epigenomic Heterogeneity of Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 4617: Novel antiestrogens, SS1020 and SS5020, for breast cancer therapy and prevention

Shinya Shibutani, Naomi Suzuki, Xiaoping Liu, Hyo Jeong Kim, Y. R. Santosh Laxmi, Yoshinori Okamoto
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 4617.
https://doi.org/10.1158/1538-7445.AM10-4617
Published: 15 April 2010
View article titled, Abstract 4617: Novel antiestrogens, SS1020 and SS5020, for breast cancer therapy and prevention
Journal Articles

SS8885 (Raloxifene diphosphate): A prodrug enhancing anti-tumor potential of raloxifene.

Yoshinori Okamoto, Xiaoping Liu, Naomi Suzuki, Kanako Okamoto, Santosh Laxmi, Shinya Shibutani
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3303.
Published: 01 May 2008
View article titled, SS8885 (Raloxifene diphosphate): A prodrug enhancing anti-tumor potential of raloxifene.
Journal Articles

NO-Aspirin inhibits the activation of NF-κB in human cancer cells

Jennie Williams, Xiaoping Liu, Ping Ji, Basil Rigas
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 3357.
Published: 01 May 2007
View article titled, NO-Aspirin inhibits the activation of NF-κB in human cancer cells
Journal Articles

NO-donating aspirin induces apoptosis via the intrinsic pathway, dissociates adherens junctions and inhibits Wnt signaling in SW480 colon cancer cells

Jianjun Gao, Xiaoping Liu, Basil Rigas
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 783.
Published: 01 May 2005
View article titled, NO-donating aspirin induces apoptosis via the intrinsic pathway, dissociates adherens junctions and inhibits Wnt signaling in SW480 colon cancer cells